Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

• Autor(es): Funk, Tjede ; Pharris, Anastasia ; Spiteri, Gianfranco ; Bundle, Nick ; Melidou, Angeliki ; Carr, Michael ; Gonzalez, Gabriel ; Garcia-Leon, Alejandro ; Crispie, Fiona ; O’Connor, Lois ; Murphy, Niamh ; Mossong, Joël ; Vergison, Anne ; Wienecke-Baldacchino, Anke K. ; Abdelrahman, Tamir ; Riccardo, Flavia ; Stefanelli, Paola ; Di Martino, Angela ; Bella, Antonino ; Lo Presti, Alessandra ; Casaca, Pedro ; Moreno, Joana ; Borges, Vítor ; Isidro, Joana ; Ferreira, Rita ; Gomes, João Paulo ; Dotsenko, Liidia ; Suija, Heleene ; Epstein, Jevgenia ; Sadikova, Olga ; Sepp, Hanna ; Ikonen, Niina ; Savolainen-Kopra, Carita ; Blomqvist, Soile ; Möttönen, Teemu ; Helve, Otto ; Gomes-Dias, Joana ; Adlhoch, Cornelia
• Data: 2021
• Identificador Persistente: http://hdl.handle.net/10400.18/8060
• Origem: Repositório Científico do Instituto Nacional de Saúde
• Assunto(s): COVID-19; Europe; SARS-CoV-2; Surveillance; Variants of Concern; Infecções Respiratórias
• Tipo de Documento: Artigo científico
• Idioma: Inglês
• Contribuidor(es): Repositório Científico do Instituto Nacional de Saúde

Descrição

We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).